Oncology - BMT/SCT News & Articles

301 Behaviour of mesenchymal stem cells from bone marrow of untreated advanced breast and lung cancer patients without bone osteolytic metastasis Clinical and Experimental Metastasis, February 18, 2013    Clinical Article

302 Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine Angiogenesis, February 18, 2013    Clinical Article

303 The recipient CXCL10 + 1642C>G variation predicts survival outcomes after HLA fully matched unrelated bone marrow transplantation Clinical Immunology, February 15, 2013    Review Article

304 Allogenic submandibular gland transplantation following hematopoietic stem cell transplantation Journal of Cranio-Maxillofacial Surgery, February 15, 2013    Review Article

305 HBV-related events after allogeneic hematopoetic stem cell transplantation in a center from Turkey Annals of Hematology, February 14, 2013    Clinical Article

306 Long Term Immune Reconstitution of Naïve and Memory T cell Pools Following Haploidentical Hematopoietic Stem Cell Transplantation Biology of Blood and Marrow Transplantation, February 14, 2013    Clinical Article

307 Rituximab, fludarabine, and total body irradiation as conditioning regimen before allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukemia: Long-term prospective multicenter study Experimental Hematology, February 14, 2013    Clinical Article

308 Long-term outcome of non-ablative booster BMT in patients with SCID Bone Marrow Transplantation, February 13, 2013    Clinical Article

309 Large granular lymphocytosis and its impact on long-term clinical outcomes following allo-SCT Bone Marrow Transplantation, February 13, 2013    Clinical Article

310 Co-transplantation of third-party umbilical cord blood-derived MSCs promotes engraftment in children undergoing unrelated umbilical cord blood transplantation Bone Marrow Transplantation, February 13, 2013    Review Article

311 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, February 13, 2013    Clinical Article

312 Molecular mechanism of microRNA involvement in genesis of myelodysplastic syndrome and its transformation to acute myeloid leukemia Hematology, February 13, 2013    Clinical Article

313 Long-term outcome after allogeneic stem-cell transplantation with reduced-intensity conditioning in patients with multiple myeloma American Journal of Hematology, February 12, 2013    Clinical Article

314 Impact of Conditioning on Outcome of Hematopoietic Stem Cell Transplantation for Wiskott-Aldrich Syndrome Journal of Pediatric Hematology/Oncology, February 12, 2013    Clinical Article

315 Induced Pluripotent Stem Cells with a Pathological Mitochondrial DNA Deletion Stem Cells, February 12, 2013    Clinical Article

316 Using human-induced pluripotent stem cells to model monogenic metabolic disorders of the liver Seminars in Liver Disease, February 12, 2013    Review Article

317 Haematopoietic stem cell transplantation: a comparison between the accreditation process performed by competent authorities and JACIE in Italy Vox Sanguinis, February 12, 2013    Clinical Article

318 Azacitidine and donor lymphocyte infusions as first salvage therapy for relapse of AML or MDS after allogeneic stem cell transplantation Leukemia, February 12, 2013    Clinical Article

319 CD34+ hematopoietic stem cells support entry and replication of poliovirus: a potential new gene introduction route Cancer Gene Therapy, February 12, 2013    Clinical Article
Exclusive Author Commentary

320 The effect of imatinib therapy on the outcome of allogeneic stem cell transplantation in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia Hematology, February 12, 2013    Clinical Article

1 Clinical significance of minimal residual disease in patients with acute leukaemia undergoing haematopoietic stem cell transplantation British Journal of Haematology, May 13, 2013

2 Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy Autoimmunity Reviews, May 21, 2013    Review Article

3 Mortality Rates of Human Metapneumovirus and Respiratory Syncytial Virus Lower Respiratory Tract Infections in Hematopoietic Cell Transplant Recipients Biology of Blood and Marrow Transplantation, May 21, 2013

4 Outcome of autologous stem-cell transplantation in relapsed or refractory Hodgkin lymphoma patients in a centre from Turkey Hematology, May 16, 2013

5 Non-relapse mortality and mycophenolic acid exposure in nonmyeloablative hematopoietic cell transplantation Biology of Blood and Marrow Transplantation, May 10, 2013

6 Late mortality after hematopoietic SCT for a childhood malignancy Bone Marrow Transplantation, May 15, 2013

7 Cost-effectiveness of the introduction of specialized oral care with laser therapy in hematopoietic stem cell transplantation Hematological Oncology, May 1, 2013

8 The significance of cytomegalovirus viremia at day 100 or more following allogeneic hematopoietic stem cell transplantation Clinical Transplantation, May 7, 2013

9 Phase angle from BIA as a prognostic and nutritional status tool for children and adolescents undergoing hematopoietic stem cell transplantation Clinical Nutrition, May 10, 2013    Review Article

10 Allogeneic hematopoietic cell transplantation for consolidation of VGPR or CR for newly diagnosed multiple myeloma Bone Marrow Transplantation, April 3, 2013

11 Azacitidine in the treatment of therapy related myelodysplastic syndrome and acute myeloid leukemia (tMDS/AML): A report on 54 patients by the Groupe Francophone Des Myelodysplasies (GFM) Leukemia Research, May 10, 2013

12 Efficacy and Safety of Busulfan-Based Conditioning Regimens for Multiple Myeloma The Oncologist, May 2, 2013    Free full text    Review Article

13 A model for the regulation of T-type Ca2+ channels in proliferation: roles in stem cells and cancer Expert Review of Anticancer Therapy, May 7, 2013    Review Article

14 Increase of suicide and accidental death after hematopoietic stem cell transplantation Cancer, March 25, 2013

15 Comparable outcome of stem cell transplant versus bortezomib-based consolidation in myeloma patients after major response to induction Hematology, May 22, 2013

16 Feasibility of an outpatient HLA haploidentical stem cell transplantation program in children using a reduced-intensity conditioning regimen and CD3-CD19 depletion Hematology, May 17, 2013

17 Unrelated donor allogeneic transplantation after failure of autologous transplantation for acute myeloid leukemia: a study from the cibmtr Biology of Blood and Marrow Transplantation, May 2, 2013

18 Unrelated cord blood transplantation: outcomes after single-unit intrabone injection compared with double-unit intravenous injection in patients with hematological malignancies Transplantation, May 28, 2013

19 Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplantation in Adults using Fludarabine, BCNU, Melphalan, and Antithymocyte Globulin (FBM-A): Outcomes depend on Disease Risk Index but not Age, Comorbidity Score, Donor Type, or HLA Mismatch Biology of Blood and Marrow Transplantation, May 13, 2013

20 Early gene expression changes by Epstein-Barr virus infection of B-cells indicate CDKs and survivin as therapeutic targets for post-transplant lymphoproliferative diseases International Journal of Cancer, May 6, 2013